PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Clinical trial NCT03442569 · COMPLETED
Trial details
- NCT number
- NCT03442569
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2020-09-21
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.